|
|
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2002-11-3490.
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2003, Vol. 102, No. 4, pp. 1290-1297
HEMATOPOIESIS
Stat5 expression is critical for mast cell development and survival
Christopher P. Shelburne,
Margaret E. McCoy,
Roland Piekorz,
Veronica Sexl,
Kwan-Ho Roh,
Sarah M. Jacobs-Helber,
Sheila R. Gillespie,
Daniel P. Bailey,
Paria Mirmonsef,
Meredith N. Mann,
Mohit Kashyap,
Harry V. Wright,
Hey Jin Chong,
L. Andrew Bouton,
Brian Barnstein,
Carlos D. Ramirez,
Kevin D. Bunting,
Steven Sawyer,
Chris S. Lantz, and
John J. Ryan
From the Department of Biology, Virginia Commonwealth University, Richmond, VA; the Department of Biology, James Madison University, Harrisonburg, VA; the Department of Biochemistry, St Jude Children's Research Hospital, Memphis, TN; the Departments of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA; the Department of Hematopoiesis, Jerome H. Holland Laboratory for the Biomedical Sciences, Rockville, MD; and The George Washington University, Washington, DC.
Interleukin-3 (IL-3) and stem cell factor (SCF) are important mast cell growth and differentiation factors. Since both cytokines activate the transcription factor signal transducer and activator of transcription 5 (Stat5), a known regulator of proliferation and survival, we investigated the effects of Stat5 deficiency on mast cell development and survival. Bone marrowderived mast cell (BMMC) populations cultured from Stat5A/B-deficient mice survived in IL-3 + SCF, but not in either cytokine alone. These cells demonstrated reduced expression of Bcl-2, Bcl-x(L), cyclin A2, and cyclin B1, with increased apoptosis and delayed cell cycle progression during IL-3 or SCF culture. Finally, the absence of Stat5 resulted in loss of in vivo mast cell development, as judged by assessments of Stat5-deficient mice and transplantation of Stat5-deficient bone marrow cells to mast cell-deficient recipient mice. These results indicate that Stat5A and Stat5B are critical regulators of in vitro and in vivo mast cell development and survival.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Mayerhofer, K. V. Gleixner, A. Hoelbl, S. Florian, G. Hoermann, K. J. Aichberger, M. Bilban, H. Esterbauer, M.-T. Krauth, W. R. Sperr, et al.
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens
J. Immunol.,
April 15, 2008;
180(8):
5466 - 5476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kashyap, A. M. Thornton, S. K. Norton, B. Barnstein, M. Macey, J. Brenzovich, E. Shevach, W. J. Leonard, and J. J. Ryan
Cutting Edge: CD4 T Cell-Mast Cell Interactions Alter IgE Receptor Expression and Signaling
J. Immunol.,
February 15, 2008;
180(4):
2039 - 2043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Burke, L. M. Ganley-Leal, A. Khatri, and L. M. Wetzler
Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?
J. Immunol.,
September 1, 2007;
179(5):
3222 - 3230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Dai, Y. Chen, L. Di, A. Podd, G. Li, K. D. Bunting, L. Hennighausen, R. Wen, and D. Wang
Stat5 Is Essential for Early B Cell Development but Not for B Cell Maturation and Function
J. Immunol.,
July 15, 2007;
179(2):
1068 - 1079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, E. Diaz-Flores, G. Li, Z. Wang, Z. Kang, E. Haviernikova, S. Rowe, C.-K. Qu, W. Tse, K. M. Shannon, et al.
Abnormal hematopoiesis in Gab2 mutant mice
Blood,
July 1, 2007;
110(1):
116 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakasato, Y. Shirakura, M. Ooga, M. Iwatsuki, M. Ito, S.-i. Kageyama, S. Sakai, M. Nagata, and F. Aoki
Involvement of the STAT5 Signaling Pathway in the Regulation of Mouse Preimplantation Development
Biol Reprod,
October 1, 2006;
75(4):
508 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Barnstein, G. Li, Z. Wang, S. Kennedy, C. Chalfant, H. Nakajima, K. D. Bunting, and J. J. Ryan
Stat5 Expression Is Required for IgE-Mediated Mast Cell Function.
J. Immunol.,
September 1, 2006;
177(5):
3421 - 3426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, X. Dai, A. L. Haas, R. Wen, and D. Wang
Proteasome-dependent down-regulation of activated Stat5A in the nucleus
Blood,
July 15, 2006;
108(2):
566 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fang, E. M. Kofoed, B. M. Little, X. Wang, R. J. M. Ross, S. J. Frank, V. Hwa, and R. G. Rosenfeld
A Mutant Signal Transducer and Activator of Transcription 5b, Associated with Growth Hormone Insensitivity and Insulin-Like Growth Factor-I Deficiency, Cannot Function as a Signal Transducer or Transcription Factor
J. Clin. Endocrinol. Metab.,
April 1, 2006;
91(4):
1526 - 1534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Wright, D. Bailey, M. Kashyap, C. L. Kepley, M. S. Drutskaya, S. A. Nedospasov, and J. J. Ryan
IL-3-Mediated TNF Production Is Necessary for Mast Cell Development
J. Immunol.,
February 15, 2006;
176(4):
2114 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kawakami and J. Kitaura
Mast Cell Survival and Activation by IgE in the Absence of Antigen: A Consideration of the Biologic Mechanisms and Relevance
J. Immunol.,
October 1, 2005;
175(7):
4167 - 4173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Silberstein, M.-J. Sanchez, M. Socolovsky, Y. Liu, G. Hoffman, S. Kinston, S. Piltz, M. Bowen, L. Gambardella, A. R. Green, et al.
Transgenic Analysis of the Stem Cell Leukemia +19 Stem Cell Enhancer in Adult and Embryonic Hematopoietic and Endothelial Cells
Stem Cells,
September 1, 2005;
23(9):
1378 - 1388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kohno, S. Yamasaki, V. L. J. Tybulewicz, and T. Saito
Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen
Blood,
March 1, 2005;
105(5):
2059 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Kataoka, N. Komazawa, E. Morii, K. Oboki, and T. Nakano
Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression
Blood,
February 1, 2005;
105(3):
1016 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Bradley, C. Couldrey, and K. D. Bunting
Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness
Blood,
April 15, 2004;
103(8):
2965 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |